Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To compare efficacy and safety of dalteparin compared to unfractionated heparin in patients
of non ST elevation acute coronary syndromes who are planned to undergo coronary
interventions (angioplasty or bypass surgery)